1.
2.
Del Med J
; 88(3): 84-8, 2016 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27215045
3.
Curr Heart Fail Rep
; 10(3): 185-9, 2013 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23728784
RESUMO
The Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARRESS-HF) trial was a prospective, randomized study comparing ultrafiltration versus pharmacological therapy in the treatment of acute decompensated heart failure (ADHF) complicated by cardiorenal syndrome Bart et al. (N Eng J Med 367:2296-2304, 1). The study found that ultrafiltration was inferior to pharmacological therapy, resulting in a significant increase in serum creatinine and serious adverse events while producing no significant difference in weight loss. The CARRESS trial calls into question the viability of ultrafiltration as a preferable treatment strategy in ADHF patients with cardiorenal syndrome.